Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells

International Journal of Biological Sciences

Volumn 6, Issue 7, 2010, Pages 700-715

  Haubold, Maike ^a   Weise, Andreas ^a   Stephan, Harald ^a   Dünker, Nicole ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Apoptosis; Bone morphogenetic protein; Cell culture; Proliferation; Retinoblastoma

Indexed keywords

EID: 78650549829     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.700     Document Type: Article

References (72)

1. Massague J, Weis-Garcia F. Serine/threonine kinase receptors: mediators of transforming growth factor beta signals. Cancer Surv 1996,27:41-64.
2. Centrella M, Rosen V, Horowitz MC, Wozney JM, Mc-Carthy TL. Transforming growth factor-ß gene family members, their receptors, and bone cell function. Endocr Rev 1995,4:211-226.
3. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth factors 2004,22:233-241.
4. Roberts AB, Sporn MB. The transforming growth factors-ßs. In: Sporn MB, Roberts AB, eds. Handbook of Experimental Pharmacology; vol. 95. Heidelberg, Germany: Springer; 1990:419-472.
5. Massague, J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990,6:597-641.
6. Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996,10:1580-1594.
7. Mehler MF, Mabie PC, Zhang D, Kessler JA. Bone morphogenetic proteins in the nervous system. Trends Neurosci 1997,20:309-317.
8. Smith A, Graham A. Restricting BMP4-mediated apoptosis in hindbrain neural crest. Dev Dyn 2001,220:276-283.
9. Lein P, Drahushuk K, Higgins D. Effects of bone morphogeneti c proteins on neural tissues. In: Vukicevic S and Sampath KT, eds. Bone Morphogenetic Proteins. Basel: Birkhauser-Verlag; 2002:289-319.
10. Duenker, N. The role of transforming growth factor beta (TGF-ß) in mediating programmed cell death in the vertebrate retina. Int Rev Cytol Survey Cell Biol 2005,245:7-40.
11. Trousse F, Esteve P, Bovolenta P. BMP4 mediates apoptotic cell death i n the devel opi ng chi ck eye. J Neurosci 2001,21:1292-1301.
12. Belecky-Adams T, Adler R. Developmental expression patterns of bone morphogenetic proteins, receptors, and binding proteins in the chick retina. J Comp Neurol 2001,430:562-572.
13. Sakuta H, Takahashi H, Shintani T, Etani K, Aoshima A, Noda M. Role of bone morphogenic protein 2 in retinal patterning and retinotectal projection. J Neuoscience. 2006,26(42):10868-10878.
14. Murali D, Yoshikawa S, Corrigan RR, Plas DJ, Crair MC, Oliver G, Lyons KM, Mishina Y, Furuta Y. Distinct developmental programs require different levels of Bmp signaling during mouse retinal development. Development 2005,132:913-923.
15. Furuta Y, Piston DW, Hogan BL. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 1997,124:2203-2212.
16. Mabie P, Mehler MF, Kessler JA. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 1999,19(16):7077-7088.
17. Graham A, Francis-West P, Brickell P, Lumsden A. The signaling molecule BMP4 mediates apoptosis in the rhomboencephalic neural crest. Nature 1994,372:684-686.
18. Franke AG, Gubbe C, Beier M, Duenker N. Transforming growth factors beta and Bone morphogenetic proteins: Cooperative players in chick and murine programmed retinal cell death. J Comp Neurol 2005,26:263-278.
19. Ro TB, Holt RU, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, Sundan A, Borset M. Bone morphogenetic protein -5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004,23:3024-3032.
20. Hjertner Ö, Hjrth-Hansen H, Börset M, Seidel C, Waage A, Sundan A. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 2001,97:516-522.
21. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Koseki T, Nishihara T, Ikeda Y. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 2000,96:2005-2011.
22. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. Bone morphogenetic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005,65(2):448-456.
23. Deng H, Ravikumar TS, Yang WL. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett 2009,281(2):220-231.
24. Deng H, Makizumi R, Ravikumar TS, Dong H, Yang WL. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells. Exp Cell Res 2007,3313(5):1033-1044.
25. Maegdefrau U, Amann T, Winkelmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol 2009,218(4):520-529.
26. Chen RH, Ebner R, Derynck R. Inactivation of type II receptor reveals two receptor pathways for the diverse TGF-ß activities. Science 1993,260:1335-1338.
27. Kimchi A, Wang XF, Weinberg RA, Cheifertz S, Massague J. Absence of TGF-ß receptors and growth inhibitory response in retinoblastoma cells. Science 1988,240:196-199.
28. Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K. Lack of Transforming growth factor-ß type II receptor expression in human retinoblastoma cells. J Cell Physiol 1998,175:305-313.
29. Howe JR, Sayed MG, Ahmed AF, Larsen-Haidle J, Merg A, Mitros FA, Vaccaro CA, Petersen GM; Giardiello FM; Timley ST, Aaltonen LA, Lynch HT. The prevalence of MADH4 and BMPRIA mutations in juvenile polyposis and absence of BMPR2 BMPR1B and ACVR1 mutations. J Med Genet 2004,41:484-491.
30. Nishanian TG, Kim JS, Foxworth A, Waldman T. Suppression of tumorigenesis and activation of wnt signaling by bone morphogenetic protein 4 in human cancer cells. Cancer Biol Therapy 2004,3:667-675.
31. Yamada N, Kato M, ten Dijke P, Yamashita TK, Heldin CH, Miyazono K, Funa K. Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. Brit J Cancer 1996,73:624-629.
32. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev 2005,16:251-263.
33. Johnson MD, O'Connell MJ, Vito F, Pilcher W. Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. J Neuropathol Exp Neurol 2009,68(11):1177-83.
34. Hanyu A., Ishidou Y, Ebisawa T, Shimanuki T, Imamura T, Miyazono K. The N-domain of Smad 7 is essential for specific inhibition of transforming growth factor-ß signalling. J Cell Biol 2001,155:1017-1028.
35. Arnold NB, Korc M. Smad7 abrogates transforming growth factor-ß1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. J Biol Chem 2005,280:21858-21866.
36. Miyazaki H, Watabe T, Kitamura T, Miyazono K. BMP signals inhibit proliferation and in vivo tumor growth of androgen- insensitive prostate carcinoma cells. Oncogene 2004,23:9326-9335.
37. Pardali K, Kowanetz M, Heldin CH, Moustakas A. Smad pathway-specific transcriptional regulation of cell cycle inhibitor p21waf1/cip1. J Cell Physiol 2005,204:260-272.
38. Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major pathways in TGF-beta superfamily signaling. Genes Cells 2002,7(12):1191-1204.
39. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Sci. STKE 2002,151:p e40
40. Yokota Y, Mori S, Narumi O, Kitajima K. In vivo function of a differentiation inhibitor, Id2. IUMBM Life 2001,51(4):207-214.
41. McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 1977,37:1003-1010.
42. Gallie BL, Albert DM, Wong JJY, Buyukmihci N, Puliafito CA. Heterotransplantation of retinoblastoma into the athymic "nude" mouse. Invest Opthlamol Vis Sci 1977,16:256-259.
43. Griegel S, Hong C, Frötschl R, Hülser DF, Greger V, Horsthemke B, Rajewski MF. Newly established human retinoblastoma cell lines exhibit an "immortalized" but not an invasive phenotype in vitro. Int J Cancer 1990,46:125-132.
44. Deitch AD, Law H, de Vere White R. A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem 1982,30(9):967-72.
45. Liu J, Wilson S, Reh T. BMP receptor 1b is required for axon guidance and cell survival in the developing retina. Dev Biol 2003,256:34-47.
46. Wordinger R, Clark A. Bone morphogenetic potein and their receptors in the eye. Exp Biol Med 2007,232:979-992.
47. Shen W, Finnegan S, Lein P, Sullivan S, Slaughter M, Higgins D. Bone morphogenetic proteins regulate ionotropic glutamate receptors in human retina. Eur J Neurosci 2004,20:2031-2037.
48. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF. Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis 2002,15:241-250.
49. Mohan RR, Kim WJ, Mohan RR, Chen L, Wilson SE. Bone morphogenetic proteins 2 and 4 and their receptors in the adult human cornea. Invest Ophthalmol Vis Sci 1998,39:2626-2636.
50. Andreev K, Zenkel M, Kruse F, Jünemann A, Schlötzer-Schrehardt U. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: Role of BMP-6 and activin-A in conjunctival scarring? Exp Eye Res 2006,83:1162-1170.
51. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000,69:217-245.
52. Gross A, McDonell JM, Korsmeyer SJ. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999,13:1899-1911.
53. Fukuda N, Saitoh M, Kobayashi N, Miyazono K. Execution of BMP-4-induced apoptosis by p53-dependent ER dysfunction in myeloma and B-cell hybridoma cells. Oncogene 2006,25(25):3509-3517.
54. Kawamura C, Kizaki M, Yamato K, Uchida H, Fukuchi Y, Hattori Y, Koseki T, Nishihara T, Ikeda Y. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 2000,96:2005-2011.
55. Lagna G, Nguyen PH, Ni W, Hata A. BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2006,291:L1059-L1067.
56. Dannenberg JH, te Riele HP. The retinoblastoma gene family in cell cycle regulation and suppression of tumorigenesis. Results Probl Cell Differ 2006,42:183-225.
57. Rivadeneira DB, Mayhew CN, Thangavel C, Sotillo E, Reed CA, Grna X, Knudsen ES. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterolgy 2010,138:1920-1930.
58. Sheahan S, Bellamy CO, Dunbar DR, Harrison DJ, Prost S. Deficiency of GI regulators P53, P21CipI and /or pRb decreases hepatocyte sensitivity to TGFß cell cycle arrest. BMC Cancer 2007,7:215-24.
59. Brubaker KD, Corey E, Brown LG, Vessella RL. Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biol 2004,91:151-160.
60. Gosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL, Kreisberg J. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochica et Biophysica Acta 2000,1497:186-196.
61. Zhu DH, Wu J, Spee C, Ryan SJ, Hinton DR. BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J Biol Chem 2009,284:9529-9539
62. Su D, Zhu S, Han X, Feng Y, Huang H, Ren G, Pan L, Zhang Y, Lu J, Huang B. BMP4-smad signalling pathway mediates adriamycin.induced premature senescence in lung cancer cells. J Biol Chem 2009,284:12153-12164
63. Chang SF, Chang TK, Peng HH, Yehr YT, Lee DY, Yeh CR, Zhou J, Cheng CK, Chang CA, Chiu JJ. BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21CIP1 and p27KIP1 regulation. Mol Endocrinol 2009,23:1827-1838.
64. Sato Y, Kobayashi H., Sasaki T, Toyama T, Kondo S, Kiriyama M, Fujii Y. Expression of Id2 mRNA in neuroblastoma and normal ganglion. Eur J Surgical Oncol 2003,29:284-287.
65. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 2003,13:410-418.
66. Perk J, Iavarone A, Benezra R. ID family of helix-loop-helix proteins in cancer. Nat Rev Cancer 2005,5:603-614.
67. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 2000,113:3897-3905.
68. Kowanetz M, Valcourt U, Bergström R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factorß and bone morphogenetic protein. Mol Cell Biol 2004,24:4241-4254.
69. Maruyama H, Kleeff J, Wildi S, Friess H, Büchler MW, Israel MA, Korc M. Id-1 and Id-2 are overexprressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 1999,155:815-822.
70. Sikder H, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003,3:525-530.
71. Clement JF, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Höffken K, Wölfl S. Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J Cancer Clin Oncol 2000,126:271-279.
72. Prabhu S, Ignatova A, Park ST, Sun XH. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol 1997,17:5888-5896.